Stay updated on Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Sign up to get notified when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.

Latest updates to the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.5.0 was added to the history, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded Revision: v3.4.3 to the history. Removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check23 days agoChange DetectedThe history shows updates to the study record across versions, including changes to Study Status, Recruitment Status, and sections such as Outcome Measures and Eligibility. It also highlights QC/Quality Control Review status across versions.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior funding notice (lapse in government funding) and the older Revision: v3.4.1 from the page.SummaryDifference0.7%

- Check52 days agoChange DetectedAdded a government funding status notice to the page. Updated the version history to v3.4.1, replacing the previous v3.4.0 entry.SummaryDifference0.7%

- Check59 days agoChange DetectedUI updates to the Record History page include a glossary toggle and color-coded highlights for changes (green for additions, red for deletions) with a new revision label (v3.4.0). Older No FEAR Act data and the revision label (v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

Stay in the know with updates to Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.